A double blind, placebo-controlled randomized trial of low-dose risperidone, cognitive-behaviour therapy, and supportive therapy in young people at ultra high risk of psychotic disorder: 12 month outcome data
Version 2 2024-06-05, 11:38Version 2 2024-06-05, 11:38
Version 1 2021-05-14, 09:49Version 1 2021-05-14, 09:49
conference contribution
posted on 2024-06-05, 11:38authored byAlison YungAlison Yung, B Nelson, L Phillips, S Francey, S Leicester, HP Yuen, M Simmons, G Berger, P Amminger, PD McGorry
A double blind, placebo-controlled randomized trial of low-dose risperidone, cognitive-behaviour therapy, and supportive therapy in young people at ultra high risk of psychotic disorder: 12 month outcome data